The article argues Eli Lilly is unlikely to announce a stock split before the end of 2026, even though its share price is near $1,200 and its valuation exceeds $1 trillion. The company last split its stock in 1997 on a 2-for-1 basis, after earlier splits in 1995, 1989 and 1986. The author notes that splits are at management's discretion, and CEO David A. Ricks, who has led the company since 2017, has not announced one. Despite this, the article considers Eli Lilly a solid long-term holding, citing its dominance in the anti-obesity drug market and its recent dividend increases.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Get briefings and signals on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the morning, midday and evening briefing of each market and important news as it happens.